Search Query :
4E9L
Fdec, a novel broadly conserved escherichia coli adhesin eliciting protection against urinary tract infections Deposition Author(s): Alteri, C. , Bertoldi, I. , Ferlenghi, I. , Fontana, M.R. , Frankel, G. , Gomes Moriel, D. , Mobley, H.L.T. , Nesta, B. , Pastorello, I. , Pizza, M. , Rappuoli, R. , Rosini, R. , Serino, L. , Smith, S. , Soriana, M. , Spraggon, G. , Veggi, D.
Date: 2012-03-21 Method: X-RAY DIFFRACTION Resolution: 1.9 Å Organism(s): Escherichia Coli Sequences Data: 4E9L_A
4MKC
Crystal structure of anaplastic lymphoma kinase complexed with ldk378 Deposition Author(s): Lee, C.C. , Spraggon, G.
Date: 2013-09-04 Method: X-RAY DIFFRACTION Resolution: 2.01 Å Organism(s): Homo Sapiens Sequences Data: 4MKC_A
4Z49
Homo sapiens fatty acid synthetase, thioesterase domain at 1.7 angstroms resolution Deposition Author(s): Spraggon, G.
Date: 2015-04-01 Method: X-RAY DIFFRACTION Resolution: 1.7 Å Organism(s): Homo Sapiens Sequences Data: 4Z49_A , 4Z49_B
4Z55
Anaplastic lymphoma kinase catalytic domain complexed with pyrazolopyrimidine derivative of ldk378 Deposition Author(s): Lee, C.C. , Spraggon, G.
Date: 2015-04-02 Method: X-RAY DIFFRACTION Resolution: 1.55 Å Organism(s): Homo Sapiens Sequences Data: 4Z55_A
5FED
Egfr kinase domain in complex with a covalent aminobenzimidazole inhibitor. Deposition Author(s): Didonato, M. , Spraggon, G.
Date: 2015-12-16 Method: X-RAY DIFFRACTION Resolution: 2.651 Å Organism(s): Homo Sapiens Sequences Data: 5FED_A
5FEE
Egfr kinase domain t790m mutant in complex with a covalent aminobenzimidazole inhibitor. Deposition Author(s): Didonato, M. , Spraggon, G.
Date: 2015-12-16 Method: X-RAY DIFFRACTION Resolution: 2.7 Å Organism(s): Homo Sapiens Sequences Data: 5FEE_A
5FEQ
Egfr kinase domain in complex with a covalent aminobenzimidazole Deposition Author(s): Didonato, M. , Spraggon, G.
Date: 2015-12-17 Method: X-RAY DIFFRACTION Resolution: 3.4 Å Organism(s): Homo Sapiens Sequences Data: 5FEQ_A
5W5J
Identification of potent and selective ripk2 inhibitors for the treatment of inflammatory diseases Deposition Author(s): Kreusch, A. , Spraggon, G.
Date: 2017-06-15 Method: X-RAY DIFFRACTION Resolution: 2.85 Å Organism(s): Homo Sapiens Sequences Data: 5W5J_A , 5W5J_B
5W5O
Identification of potent and selective ripk2 inhibitors for the treatment of inflammatory diseases. Deposition Author(s): Kreusch, A. , Spraggon, G.
Date: 2017-06-15 Method: X-RAY DIFFRACTION Resolution: 2.89 Å Organism(s): Homo Sapiens Sequences Data: 5W5O_A , 5W5O_B , 5W5O_C , 5W5O_D , 5W5O_E , 5W5O_F , 5W5O_G , 5W5O_H , 5W5O_I , 5W5O_J , 5W5O_K , 5W5O_L , 5W5O_M , 5W5O_N , 5W5O_O , 5W5O_P
6BHZ
Trastuzumab fab d185a (light chain) mutant. Deposition Author(s): Didonato, M. , Spraggon, G.
Date: 2017-10-31 Method: X-RAY DIFFRACTION Resolution: 1.75 Å Organism(s): Homo Sapiens Sequences Data: 6BHZ_H , 6BHZ_I , 6BHZ_L , 6BHZ_M